About Novartis Oncology

Novartis Oncology, a business unit within the Novartis group company, strives to become the world's premier oncology business by consistently discovering, developing and making broadly available novel therapies that may improve and extend the lives of people living with cancer. The Novartis Oncology business is headquartered in the United States in Florham Park, New Jersey.

Supporting oncology healthcare professionals starts with a broad understanding that cancer is a complex group of diseases fueled by many underlying mechanisms. Research and development at Novartis is built on recent discoveries in molecular genomics, rational drug design and state-of-the-art drug discovery technologies. To support these efforts, the company makes considerable investments in technologies and expertise both internally and externally.

Pride in our Portfolio

The robust R&D program has enabled Novartis to offer a broad range of innovative therapies to help physicians meet patient needs. Learn about our products. Novartis today has one of the broadest and deepest oncology pipelines in the industry.

Support for Patients and Professionals

In addition to its key therapeutics, Novartis advances the treatment and care of cancer through unprecedented levels of product support and financial assistance for patients. Novartis Oncology seeks to build successful partnerships by identifying areas of collaboration to benefit cancer patients.

Novartis Oncology U.S. supports over 150 national and local patient advocacy programs to promote patient education and disease awareness. We fund a rich clinical trial program across the U.S., some trials sponsored directly by Novartis Oncology, others independently-led. In the U.S., Novartis Oncology supports over 150 national and local patient advocacy programs to promote patient education and disease awareness. By partnering with members of the oncology community, Novartis effectively expands research and development as well as promotes patient education and disease awareness. The company is devoted to developing and maintaining a sensitive understanding of the needs of healthcare professionals and patients. Ultimately, these efforts are intended to help health professionals accomplish their primary goal of improving patient lives.

Contact Information
Customer Interaction Center
Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, NJ 07936-1080
Phone: 1-888-669-6682

Commitment to Patients ›

We are committed to building strong relationships with our patient advocacy partners.
More about our commitment to patients ›

Grant Requests ›

Learn more about grant opportunities for professsional education and patient advocacy from Novartis Oncology
Learn more ›

CEO Cancer Gold Standard ›

Novartis Oncology Accredited as CEO Cancer Gold Standard™ Organization Learn more ›